39 reports

Biomarker Technology Platforms for Cancer Diagnoses and Therapies

399 pages • By TriMark Publications

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred....

2 720 3 400 2 176
Jan 2014

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intel

151 pages • By Allied Market Research

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020Biomarkers...

3 612 4 515 2 890
Dec 2013

Global Imaging Biomarkers Market 2014-2018

49 pages • By Infiniti Research Limited

TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Imaging Biomarkers market has also been witnessing the emergence of personalized medicines. However, the...

1 600 2 000 1 280
Nov 2013

Biomarkers: Discovery Techniques and Applications - A Global Market Overview

350 pages • By Industry Experts

The potential offered by biomarkers in shaping the outcomes of clinical trials, identifying new drug targets and developing diagnostic assays for detecting diseases early is immense, which has ensued in a large number of scientific publications coming out over the past two decades. Biomarker research encompasses widespread fields of discipline,...

3 600 4 500 2 880
Nov 2013

Molecular Diagnostics in Cancer Testing

232 pages • By TriMark Publications

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics,...

2 720 3 400 2 176
Nov 2013

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 201

327 pages • By MarketsandMarkets

Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018) A biomarker is an identifiable and measurable characteristic, which...

3 720 4 650 2 976
Sep 2013

Companion Biomarkers in Drug Development

356 pages • By TriMark Publications

Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid...

2 720 3 400 2 176
Aug 2013

Biomarkers: Technological and Commercial Outlook 2013-2023

178 pages • By Visiongain

Report DetailsBiomarkers - how to find R&D trends and potential salesWhat's the outlook for biomarkers? Visiongain's updated report predicts revenues to 2023. There you find the best places for sales growth, also understanding trends and opportunities.That study gives you revenue forecasts to 2023 at overall...

2 141 2 548 1 606
Jul 2013

Molecular Biomarkers for Cancer Detection and Management

By CHI Insight Pharma Reports

New to Insight Pharma Reports is Molecular Biomarkers for Cancer Detection and Management: Technologies, Markets, and Trends. This report focuses on recent progress and new directions in this highly dynamic diagnostic field. Covering extensive background and history, commercialization, and marketing trends of cancer biomarker technologies,...

1 996 2 495 1 597
Jul 2013